Bozeman, Montana-based Next Frontier Capital closed its inaugural venture capital fund, at $21.2m.
More than 75 individual and institutional Limited Partners invested in the fund.
Led by General Partners Will Price and Richard Harjes, Next Frontier Capital, seeks to lead or co-lead venture investments between $200k and $1.5m in Montana-based promising technology and healthcare ventures.
to talent, partners, and customers. It also considers non-Montana investment candidates on a select basis.
The fund has made three investments over the last year, in biotech, software and clean water technology firms. These include:
– SiteOne Therapeutics, a Bozeman, Montana-based developer of novel therapeutics and diagnostics to treat acute and chronic pain without the limitations of existing therapies, such as NSAIDs and opioids;
– Submittable, a Missoula, Montana-based provider of cloud-based online submission management solutions for any size publisher, school or organization; and
– Clearas, a Missoula, Montana-based provider of advanced, biologic-based, water treatment technology for municipal and industrial point source dischargers.